North America Metagenomics Market to Reach US$ 106.9 Mn at CAGR of 8.0% by 2025 | The Insight Partners

North America Metagenomics Market to 2027- Regional Analysis and Forecasts by Product (Instruments & Software and Consumables), Application (Clinical Diagnostics, Drug Discovery Metagenomics and Others) and Country

Publication Month: Feb 2019 | Report Code: TIPRE00003322 | No. of Pages: 139 | Category: Biotechnology | Status: Published
The North America Metagenomics market is expected to reach US$ 106.9 Mn in 2027 from US$ 55.2 Mn in 2018. The market is estimated to grow with a CAGR of 8.0% from 2018-2027.

The growth of the market is driven by the factors such as increasing investments in the metagenomics and diverse applications of metagenomics, in the North America region. Whereas, high cost associated with metagenomics is likely to have a negative impact on the growth of the market in the coming years.

Metagenomics is the upcoming field of the biotechnology and the extensive researches are being conducted in the labs across the world. Several clinical labs in United States, have already undertaken the considerable lengths to upgrade and validate a wide range of protocols for agnostically detecting viral, bacterial, fungal and eukaryotic parasite nucleic acid in different specimens of patient to benefit in diagnosis for particularly intractable cases.

The extensive research need is pushing the venture capitals or academic medical centers to subsidize the prices for the metagenomics testing. They help to conduct researches to carry out testing in US$ 2000 - US$ 3000 per sample.

Major market players such as Illumina based in California have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing. For instance, Illumina’s NovaSeq 6000 Sequencing System releases groundbreaking innovations. The system enables accessible throughput and flexibility for virtually any sequencing method, genome and scale of project.

Owing to factor that the cost of the metagenomics is been subsidize by the venture capitalists and the innovative technology by the market leaders that enables the access to the metagenomics studies are likely to propel the growth of the market in the forecast period.

US is anticipated to lead the adoptions of Metagenomics across the North American region through the forecast period. The major players headquartered in the US are also focused towards developing innovative and novel products and bringing them into market, which is also one of the major factors driving the growth of US in the North America metagenomics market. Moreover, the companies are significantly investing under research and development to come-up with medical products that are derived from natural microbial sources. For instance, in August 2018, Genentech and Lodo initiated a US$ 1 Bn project to develop unique, natural products from the microbial DNA found in soil. Under the collaboration, Genentech will use Lodo’s metagenome-prospecting platform to identify novel small molecules with the potential for treating disease.

Exhibit: Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Bn)



NORTH AMERICA METAGENOMICS - MARKET SEGMENTATION

By Product

  • Instruments & Software
  • Consumables
NORTH AMERICA METAGENOMICS - MARKET SEGMENTATION

By Application
  • Clinical Diagnostics
  • Drug Discovery
By Country
  • U.S.
  • Canada
  • Mexico
Companies Mentioned
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories, Inc.
  • Perkinelmer Inc.
  • Illumina Inc.
  • F Hoffman-La Roche Ltd.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Bioscience of California, Inc.

PART 1. iNTRODUCTION

1.1      Scope of the Study

1.2      The Insight Partners Research Report Guidance

PART 2. North America Metagenomics Market – Key takeaways

PART 3. North America Metagenomics market –  market landscape

3.1      overview

3.2      market segmentation

3.2.1      North America Metagenomics Market – By Product

3.2.2      North America Metagenomics Market – By Application

3.2.3      North America Metagenomics Market – By Country

3.3      PEST Analysis

3.3.1      North America – PEST Analysis

PART 4. North America Metagenomics market- Key Market Dynamics

4.1      Key Market Drivers

4.1.1      Increasing Investments in the field of Metagenomics

4.1.2      Benefits of Metagenomics Over Traditional Methods

4.1.3      Diverse Potential Applications of Metagenomics

4.2      Key Market Restraints

4.2.1      High Cost Associated With Metagenomics

4.3      Key Market Opportunities

4.3.1      Precision Metagenomic Analysis In Personalised Medicine

4.4      Key Market Trends

4.4.1      Growing Trend of  Molecular-Based Approaches

4.5      Impact analysis

PART 5. Metagenomics market – North America Analysis

5.1      North America Metagenomics market Revenue Forecasts and Analysis

5.2      Market positioning

5.3      PERFORMANCE OF KEY PLAYERS

Illumina, Inc.

Qiagen 

5.4      expert opinions

PART 6. North America Metagenomics market Analysis –  By Product

6.1      Overview

6.2      NORTH AMERICA metagenomics MARKET, BY product, 2018 & 2027 (%)

6.3      North America Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

6.4      Instruments & Software Market

6.4.1      Overview

6.4.2      North America Instruments & Software Market Revenue and Forecasts to 2027 (US$ Mn)

6.5      Consumables Market

6.5.1      Overview

6.5.2      North America Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

PART 7. North America Metagenomics market Analysis –  By Application

7.1      Overview

7.2      NORTH AMERICA Metagenomics MARKET, BY application, 2018 & 2027 (%)

7.3      Clinical Diagnostic Market

7.3.1      Overview

7.3.2      North America Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

7.4      Drug Discovery metagenomics Market

7.4.1      Overview

7.4.2      North America Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

7.5      Others Market

7.5.1      Overview

7.5.2      North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

PART 8. North America Metagenomics market Revenue and Forecasts  to 2027

8.1      Overview

8.2      North America metagenomics Market Revenue And Forecasts to 2027, By Country (%)

8.3      US Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.3.1      US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.3.2      US Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.3.3      US Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.4      Canada Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.4.1      Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.4.2      Canada Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.4.3      Canada Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

8.5      Mexico Metagenomics market Revenue and Forecasts to 2027 (US$ Mn)

8.5.1      Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

8.5.2      Mexico Metagenomics Market Revenue And Forecasts to 2027, By Product (US$ Mn)

8.5.3      Mexico Metagenomics Market Revenue And Forecasts to 2027, By Application (US$ Mn)

PART 9. Metagenomics Market –Industry Landscape

9.1      Overview

9.2      Growth Strategies in the Metagenomics Market, 2015-2018

9.3      Organic Developments

9.3.1      Overview

9.4      Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

9.5      Product Launch

9.5.1      Recent Product Launch By Players In The Metagenomics Market

9.6      Product approval

9.6.1      Recent Product Approval By Players In The Metagenomics Market

9.7      Expansion & Others

9.7.1      The Metagenomics Market By Expansion & Other Growth Strategies

9.8      Inorganic developments

9.8.1      Overview

9.9      inOrganic Growth Strategies in the Metagenomics Market, 2015-2018

9.10    Acquisitions

9.10.1 Acquisitions By Players In The Metagenomics Market

9.11    Agreements

9.11.1 The Metagenomics Market By Agreements

9.12    Partnership & Collaboration

9.12.1 Partnership By Players In The Metagenomics Market

PART 10. Metagenomics Market–Key company profiles

10.1    Merck KGaA

10.1.1    Key Facts

10.1.2    Business Description

10.1.3    Financial Overview

10.1.4    Product Portfolio

10.1.5    SWOT Analysis

10.1.6    Key Developments

10.2    Thermo Fisher Scientific, Inc.

10.2.1    Key Facts

10.2.2    Business Description

10.2.3    Financial Information

10.2.4    Product Portfolio

10.2.5    SWOT Analysis

10.2.6    Key Developments

10.3    Agilent Technologies, Inc.

10.3.1    Key Facts

10.3.2    Business Description

10.3.3    Financial Overview

10.3.4    Product Portfolio

10.3.5    SWOT Analysis

10.3.6    Key Developments

10.4    QIAGEN

10.4.1    Key Facts

10.4.2    Business Description

10.4.3    Financial Overview

10.4.4    Product Portfolio

10.4.5    SWOT Analysis

10.4.6    Key Developments

10.5    Bio-Rad Laboratories, Inc.

10.5.1    Key Facts

10.5.2    Business Description

10.5.3    Financial Information

10.5.4    Product Portfolio

10.5.5    SWOT Analysis

10.5.6    Key Developments

10.6    Perkin Elmer, inc.

10.6.1    Key Facts

10.6.2    Business Description

10.6.3    Financial Overview

10.6.4    Product Portfolio

10.6.5    SWOT Analysis

10.6.6    Key Developments

10.7    Illumina, Inc.

10.7.1    Key Facts

10.7.2    Business Description

10.7.3    Financial Overview

10.7.4    Product Portfolio

10.7.5    SWOT Analysis

10.7.6    Key Developments

10.8    F. Hoffmann-La Roche Ltd.

10.8.1    Key Facts

10.8.2    Business Description

10.8.3    Financial Overview

10.8.4    Product Portfolio

10.8.5    SWOT Analysis

10.8.6    Key Developments

10.9    Oxford Nanopore Technologies Ltd.

10.9.1    Key Facts

10.9.2    Business Description

10.9.3    Financial Overview

10.9.4    Product & Services Portfolio

10.9.5    SWOT Analysis

10.9.6    Key Developments

10.10  Pacific Bioscience of California, inc.

10.10.1  Key Facts

10.10.2  Business Description

10.10.3  Financial Overview

10.10.4  Product & Services Portfolio

10.10.5  SWOT Analysis

10.10.6  Key Developments

PART 11.  Appendix

11.1    About The Insight Partners

11.2    Glossary of Terms

11.3    Methodology

11.3.1    Coverage

11.3.2    Secondary Research

11.3.3    Primary Research

 

LIST OF TABLES

TABLE 1.           North America Metagenomics market Revenue And Forecasts to 2025, By product (US$ Mn)

TABLE 2.           US Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 3.           US Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 4.           Canada Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 5.           Canada Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 6.           Mexico Metagenomics market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 7.           Mexico Metagenomics market Revenue And Forecasts to 2025, By application (US$ Mn)

TABLE 8.           Recent Product Launch in the Metagenomics Market

TABLE 9.           Recent Product Approval and Enhancements in the Metagenomics Market

TABLE 10.         the Metagenomics Market by Exansion & Others Strategies

TABLE 11.         Acquisitions in the Metagenomics Market

TABLE 12.         the Metagenomics Market by Agreements

TABLE 13.         partnership in the Metagenomics Market

TABLE 14.         Glossary of Terms, Metagenomics market

 

LIST OF FIGURES

FIGURE 1.         US Metagenomics market, Revenue (US$ Mn), By 2018 & 2027

FIGURE 2.         North America Metagenomics Market By product, Market Share (%), 2018

FIGURE 3.         North America Metagenomics Market By application, Market Share (%), 2018

FIGURE 4.         Metagenomics market Segmentation

FIGURE 5.         North America PEST Analysis

FIGURE 6.         Metagenomics market impact analysis of drivers & Restraints

FIGURE 7.         North America Metagenomics market – Revenue Forecasts and Analysis – 2017- 2027

FIGURE 8.         North America metagenomics market By Product, 2018 & 2027 (%)

FIGURE 9.         North America Instruments & software Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 10.       North America Consumables Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 11.       North America Metagenomics market By application, 2018 & 2027 (%)

FIGURE 12.       North America Clinical Diagnostic Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 13.       North America Drug Discovery Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 14.       North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 15.       North America Metagenomics Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 16.       US Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.       Canada Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.       Mexico Metagenomics Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.       Growth Strategies in the Metagenomics Market, 2015-2018

FIGURE 20.       Organic Growth Strategies in the METAGENOMICS Market, 2015-2018

FIGURE 21.       Inorganic developments in the Metagenomics Market, 2015-2018

The List of Companies

  1. Merck KGaA
  2. Thermo Fisher Scientific Inc.
  3. Agilent Technologies
  4. Qiagen
  5. Bio-Rad Laboratories, Inc.
  6. Perkinelmer Inc.
  7. Illumina Inc.
  8. F Hoffman-La Roche Ltd.
  9. Oxford Nanopore Technologies Ltd.
  10. Pacific Bioscience of California, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the metagenomics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global metagenomics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.